Crescent Biopharma (CBIO) Operating Margin (2013 - 2026)
Crescent Biopharma (CBIO) reported Operating Margin of -2380.08% for Q1 2026.
Powered by 
Analysis
Crescent Biopharma (CBIO) Operating Margin (2013 - 2026) Analysis & Trends
For FY2025, Crescent Biopharma posted Operating Margin of -1407.52%, up 2873.50 percentage points from FY2024.
- Operating Margin has a five-year change of -900.69 percentage points (FY2020 to FY2025).
- By year, Operating Margin came in at -4281.03% in FY2024 (+388471.90 pp), -392752.93% in FY2023 (-329548.50 pp), -63204.43% in FY2022 (-57733.74 pp) and -5470.69% in FY2021 (-4963.85 pp).
- The Q1 2026 figure ranks as the highest quarterly Operating Margin since Q4 2023.
- The high point for year-over-year Operating Margin in five years was Q2 2022 (a gain of 10126197.20 percentage points); the low point was Q1 2022 (a drop of 206032.93 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 52.42% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 30.89% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 32.98% |
| 10 | Crescent Biopharma | 418.60 Mn | -288.70 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -2,380.08% |
| Sep 30, 2024 | -6,088.12% |
| Jun 30, 2024 | -3,948.98% |
| Mar 31, 2024 | -2,937.69% |
| Dec 31, 2023 | -1,872.50% |
| Sep 30, 2023 | -1,606.19% |
| Jun 30, 2023 | -1,330.78% |
| Mar 31, 2023 | -1,880.97% |
| Jun 30, 2022 | -17,804.21% |
| Mar 31, 2022 | -207,385.91% |
| Dec 31, 2021 | -98,870.20% |
| Sep 30, 2021 | -20,028.82% |
| Jun 30, 2021 | -10,144,001.41% |
| Mar 31, 2021 | -1,352.98% |
| Dec 31, 2020 | -9,554.94% |
| Sep 30, 2020 | -1,372.73% |
| Mar 31, 2020 | -90.09% |
| Dec 31, 2019 | -2,518.94% |
| Dec 31, 2018 | -1,420.77% |
| Sep 30, 2016 | -42,631.11% |
API Access
Crescent Biopharma Operating Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-margin&ticker=CBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-margin", "ticker": "CBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-margin&ticker=CBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();